Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9587036 Cross-species-specific PSMAxCD3 bispecific single chain antibody

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 1, 2011
Date of Patent
March 7, 2017
Patent Application Number
13638223
Patent Citations Received
‌
US Patent 11884733 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11939384 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11884732 Proteins binding HER2, NKG2D and CD16
0
‌
US Patent 11970540 Anti-BCMA heavy chain-only antibodies
0
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer
0
Patent Inventor Names
Susanne Mangold
0
Tobias Raum
0
Peter Kufer
0
Carola Steiger
0
Doris Rau
0
Evelyne Schaller
0
Matthias Klinger
0
Patrick Hoffmann
0
Petra Fluhr
0
Ralf Lutterbuese
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9587036
Patent Primary Examiner
‌
Julie Wu

Find more entities like US Patent 9587036 Cross-species-specific PSMAxCD3 bispecific single chain antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo